生物学效应分析——心理性应激和躯体性应激对鼠脾杀伤细胞影响的异同

阐明心理性应激和躯体性应激对鼠脾杀伤细胞影响的异同。应用Communication box系统分别使小鼠连续负荷心理性应激和躯体性应激3 d后,以51Cr释放法检测鼠脾NK、LAK、CTL细胞杀伤活性。负荷心理性应激和躯体性应激后,可导致鼠脾NK细胞、LAK细胞杀伤活性降低（P〈0.05,P〈0.01）;两者均可明显降低C57BL/6小鼠脾CTL细胞活性（P〈0.01）,躯体性应激比心理性应激对CTL细胞活性有较强的抑制作用。心理性应激和躯体性应激均可降低脾NK、LAK、CTL细胞杀伤活性。     

躯体性应激和心理性应激对鼠脾NK细胞受体表达的影响

阐明躯体性应激和心理性应激降低NK细胞杀伤活性的机制及异同。应用Communication box系统分别使小鼠连续负荷躯体性应激和心理性应激后,以~(51)Cr释放法检测鼠脾NK、LAK细胞的杀伤活性;以流式细胞术检测鼠脾细胞、LAK细胞中NK细胞受体的表达水平。结果表明,躯体性应激和心理性应激均可降低鼠脾NK、LAK细胞的杀伤活性,但对脾细胞、LAK细胞中NK细胞受体表达的影响却不同,提示躯体性应激和心理性应激影响NK细胞功能的机制不同。     

急性恐惧应激对大鼠行为、激素水平及脑Erk1/2活化表达的影响

目的:探讨急性恐惧应激对大鼠情感行为、激素水平及不同脑区Erk1/2活化表达的影响。方法:采用足电击 白噪声刺激方式建立急性恐惧应激大鼠模型,观察其情感行为的改变;放射免疫法及荧光分光光度法检测血浆和脑组织激素水平;Westernblot检测Erk1/2的活化表达。结果:应激后大鼠旷场活动性降低、拒俘反应性增加、惊吓反应增强(P<0.01);血浆及脑组织去甲肾上腺素、5-羟色胺、皮质醇水平增高,而肾上腺髓质素水平降低(P<0.01);海马、纹状体、前额皮质、小脑等脑区磷酸化Erk1/2蛋白的表达均显著增高(P<0.01)。结论:急性恐惧应激可以显著影响大鼠的情感行为和激素水平,Erk1/2蛋白磷酸化水平的增高可能参与了急性恐惧应激所致的情感行为异常。     

κ-阿片受体拮抗剂MR-2266-BS对ACTH和催乳素释放的影响

颈外静脉预置硅橡胶导管的清醒、自由活动的大鼠,静脉内注射κ-阿片受体特异拮抗剂MR-2266-BS,观察它对促肾上腺皮质激素(ACTH)和催乳素静息分泌和限制性应激时释放的影响。结果表明,3mg/kg/0.5ml的MR-2266-BS显著阻断限制性应激时血浆ACTH水平的增加,但有进一步升高应激时血浆催乳素水平的趋势;对两种激素的静息分泌均无影响。给MR-2266-BS的剂量达6mg/kg/0.5ml时,则显著增加血浆ACTH的静息水平,对催乳素的静息分泌仍无影响;此剂量使应激时血浆中两种激素的水平,均呈现进一步上升。这些结果提示,内源性阿片样物质可能参与垂体前叶激素释放的调控。其中κ-阿片受体及其内源性配体,对ACTH的释放既有兴奋也有抑制性作用;对催乳素的影响似乎只抑制其应激时的大量释放。     

爪蟾卵母细胞表达猫脊髓背根神经节初级感觉神经元的速激肽受体

提取猫的背根神经节 (DRG)中的Poly(A) ⁺RNA ,注射到非洲爪蟾卵母细胞中进行表达 ,2d后通过双电极电压箝技术检测爪蟾卵母细胞对速激肽受体激动剂的反应 .NK- 1受体特异激动剂 [Sar⁹,Met(O₂ ) ¹¹]SP (Sar -SP) ,NK -2受体特异激动剂 [β- Ala⁸] neurokininA ( 4～ 1 0 ) (Ala -NKA)和神经激肽A(NKA)产生相似的内向电流 .由一个快速的锋电流和持续数分钟的振荡电流组成 .Sar- SP的反应只被NK- 1受体特异拮抗剂L- 6 6 8,1 6 9( 1 μmol/L)阻断 ,而NKA及Ala- NKA的反应则仅被NK -2受体特异拮抗剂L -6 5 8,877( 1 μmol/L)阻断 .注射猫脊髓背角Poly(A) ⁺RNA在爪蟾卵母细胞中表达的速激肽受体的反应基本相似 .这些速激肽受体的反应都具有强烈的脱敏性 .这是首次在爪蟾卵母细胞受体表达系统证明DRG神经元有速激肽NK- 1和NK -2受体 ,从而提示在伤害性初级传入末梢上可能存在速激肽突触前自身受体     

常用实验动物不同组织部位肥大细胞异质性的组织学特点比较

目的探讨并比较六种常用实验动物不同部位肥大细胞异质性的形态学特点。方法应用麻醉后处死的方法,取小鼠、大鼠、豚鼠、兔、犬和猴的皮肤、肺脏、乙状结肠和脾脏组织,经4%中性缓冲甲醛溶液或Bouin’s液固定后,制作常规组织切片,分别作HE、甲苯胺蓝、阿尔新蓝-藏红和P物质免疫组织化学染色,镜下观察并应用彩色病理图像分析软件进行形态学分析;另取皮肤组织固定于磷酸缓冲戊二醛溶液,制作常规超薄切片,透射电镜下观察肥大细胞超微结构。结果六种动物不同组织中肥大细胞各有其分布特点,且在形态大小、异染性及染色特性等方面表现各异,肥大细胞密度和形态学参数差异有显著性（P〈0.05）;豚鼠、犬和猴皮肤肥大细胞颗粒具有特殊亚微结构;小鼠皮肤组织内可见P物质免疫阳性肥大细胞和神经纤维,犬脾脏内可见P物质免疫阳性肥大细胞。结论在六种实验动物的同一组织中以及同一种动物不同组织中,肥大细胞具有明显的异质性,此异质性对采用实验动物开展与肥大细胞功能相关的动物实验研究具有重要参考价值。     

脑室注射5-HT对应激后胃粘膜中ATP酶活性及ATP和ADP含量的影响

中枢5-羟色胺(5-HT)可通过兴奋下丘脑-垂体-甲状腺轴加重大鼠冷冻加束缚应激性溃疡。本工作进一步观察了脑室注射5-HT对胃粘膜代谢的影响及其与甲状腺激素的关系。应激180min大鼠的胃粘膜ATP酶的活性较非应激发对照鼠升高42.6％;如应激前10min向侧脑室注射5-HT50μg或腹腔注射四碘甲腺原氨酸(T_4)200μg/kg,均匀进一步提高应激后胃粘膜ATP酶的活性。在侧脑室注射5-HT后应激180min的鼠,血浆三碘甲腺原氨酸(T_3)和T_4水平均与胃粘膜ATP酶的活性呈明显的正相关关系。用高效液相层析测定观察到,应激鼠胃粘膜ATP和ADP水平均明显低于非应激鼠,分别为非应激鼠的70.3％和76.8％。腹腔注射T_4进一步减少应激后胃粘膜ATP和ADP的水平。这些结果提示,中枢5-HT可能通过甲状腺激素提高胃粘膜ATP酶的活性,使ATP和ADP含量下降,这可能与其加重溃疡的机制有关。     

小鼠sIL1ra基因克隆与其在骨髓抑制恢复中的功能研究

目的：构建鼠分泌型白细胞介素1受体拮抗剂（sIL1ra）基因的真核表达载体,进行体内表达,并研究其在5氟尿嘧啶（5-FU）所致骨髓抑制恢复中的作用。方法：根据鼠sIL1ra基因序列设计特异引物,以RT—PCR克隆其编码序列,并构建至phCMV真核表达载体中,通过胫前肌肌肉注射、随后电击转染等方法获得了该基因在小鼠体内的高效表达,并研究了sIL1m的药效学功能。结果：体内表达sIL1ra能增加5-FU注射后小鼠外周血白细胞数以及骨髓细胞数（P〈0．05或P〈0.01）。结论：体内转染sIL1ra可以促进小鼠骨髓抑制后造血的恢复。     

慢性复合应激对大鼠学习记忆功能及脑ERK表达活化的影响

目的：研究慢性复合应激对大鼠学习记忆的影响,以及大脑细胞外信号调节激酶（ERK）表达活化的变化,探讨慢性应激致学习记忆损害的分子机制。方法：采用低温暴露、足电击、白噪声、束缚、尾部悬吊、睡眠剥夺、水平震荡等刺激方式,建立慢性复合应激大鼠模型。Morris水迷宫实验观察应激对学习记忆的影响;放射免疫法检测血清皮质酮（CORT）含量;Western blot检测ERK的表达。结果：应激组大鼠水迷宫训练潜伏期较对照组延长,应激3周时有所恢复,但4周时大鼠的训练潜伏期再次显著延长（P〈0.05）。同时应激组大鼠血清CORT水平增高,海马、前额皮质P-ERK水平降低（P〈0.05）,两者在应激3周时均出现短时恢复,但4周时再次下调。结论：海马、前额皮质ERK蛋白磷酸化水平的改变可能参与了慢性复合应激损害学习记忆的分子机制。     

大鼠严重烧伤后心肌细胞GRP94表达变化及其意义

目的观察严重烧伤大鼠心肌细胞内质网应激蛋白表达的改变及其意义,以探讨严重烧伤后心肌损伤与内质网应激的关系。方法建立大鼠30％Ⅲ度烫伤模型,酶联免疫法检测血浆中心肌肌钙蛋白T（cTnT）含量,放射免疫法检测血浆中TNFα的含量,RT-PCR和免疫组化分析GRP94的表达。结果烧伤组大鼠伤后3h血浆中cTnT含量即呈显著升高（P〈0．01）,心肌中GRP94 mRNA和蛋白表达于烧伤后3h显著性升高,12h达峰值,24h还呈显著升高;大鼠烧伤后3h心肌中Caspase-3活性开始升高,12h达高峰,48h后仍显著高于对照组。牛磺酸治疗组GRP94的表达和Caspase-3活性较烧伤组均有显著性降低（P〈0．05）。结论严重烧伤可引起心肌细胞内质网应激,牛磺酸对烧伤后早期心肌损害有保护作用。     

Association between histamine-containing mast cells and sensory nerves in the skin and airways of control and capsaicin-treated pigs

Summary The association between mast cells (visualized by routine staining and immunohistochemistry for histamine) and capsaicin-sensitive nerves (containing calcitonin gene-related peptide (CGRP) and substance P (SP)) was studied in the pig. In the 1-ethyl-3(3-diethylaminopropyl)carbodiimide (EDCDI)-fixed skin tissue, histamine-containing mast cells and CGRP/SP-positive nerves were found in close association around blood vessels. In the EDCDI-fixed airway mucosa, only single histamine-containing mast cells were detected. However, many alcian blue-positive mast cells were found, sometimes close to the airway epithelium where CGRP/SP-containing nerve fibres were absent 2 days after systemic capsaicin pretreatment, but no changes in the number and distribution of tissue mast cells, granulocytes or lymphocytes, or the number of blood leukocytes were detected. Local injection of allergen, histamine and capsaicin into the skin of pigs actively sensitized with ascaris antigen caused a rapid light red-flare (vasodilation) reaction. Allergen and histamine, but not capsaicin, also produced plasma protein extravasation. In contrast to the absent flare, the protein extravasation response still occurred in capsaicin-treated pigs. The sensitivity to ascaris antigen was mediated by an IgE-like antibody. We conclude that a functional and morphological relationship exists between histamine-containing mast cells and capsaicin-sensitive sensory nerves in the pig skin. Mast cells and sensory nerves are also found in the airway mucosa and appear to be closely associated with the epithelium.     

Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells

Tachykinins such as SP (substance P) may be involved in the progression of gastric adenocarcinoma through binding to NK-1 receptor. However, the existence and relationship between SP and gastric cancer progression and differentiation remained unknown. We have studied the NK-1 receptor in human gastric cancer tissue and MKN45 cell line and found SP-containing nerve fibres in human gastric cancer and found that the amounts of SP-positive nerves were related to gastric cancer differentiation. SP could promote proliferation, adhesion, migration and invasion of MKN45 cells in vitro. In addition, the intracellular calcium level of MKN45 cells was elevated after SP stimulation, and administration of CRACs (calcium release-activated calcium channels) inhibitor SKF-96365 could partially abolish these effects induced by SP. These results demonstrated that NK-1 receptor and SP-containing nerves existed in human gastric cancer; SP positive nerves may play an important role in human gastric cancer progression, and calcium is critically significant among SP-induced biological effects.     

Neonatal transection alters the percentage of substance-P-positive trigeminal ganglion cells that contribute axons to the regenerate infraorbital nerve

Neonatal transection results in a marked reduction of the number of trigeminal (V) ganglion cells that contribute axons to the regenerate infraorbital nerve (ION; Jacquin and Rhoades, 1985; Chiaia et al., 1987). Such lesions also produce a profound deafferentation of the V brain stem complex that appears to spare the innervation of layers I and II of subnucleus caudalis (SpC) by substance-P-positive (SP-positive) primary afferents (Jacquin and Rhoades, 1985; Rhoades et al., 1988). In the present study, we combined retrograde tracing with immunocytochemistry to determine whether neonatal transection of the ION alters the percentage of SP-positive V ganglion cells that contribute axons to this V branch upon regeneration. In V ganglia ipsilateral to the intact ION (n = 8), 11.6% +/- 3.2% of the cells labeled after application of true blue (TB) to the ION were also SP-positive. In ganglia ipsilateral to the neonatally damaged nerve (n = 8), 18.6% +/- 4.7% of the cells labeled after application of TB to the regenerate ION were also SP-positive (p less than 0.001). We also compared the SP content of intact ganglia (n = 10) with that of ganglia ipsilateral to the damaged nerve (n = 10) by means of radioimmunoassay. The normal V ganglia contained (mean +/- SD) 3496 +/- 774 pg SP/mg protein. The value for the ganglia ipsilateral to the damaged nerve was 5533 +/- 1746 pg SP/mg protein (p less than 0.01). There was no significant difference between SP levels on the control and partially deafferented sides of the brain stem in neonatally nerve-damaged adult rats. In one additional experiment, we injected TB into both vibrissa pads of seven rats on the day of birth prior to transection of the ION. After an 8-hr delay, the nerve on one side was then cut and allowed to regenerate, and both V ganglia were then processed for immunocytochemistry. On the nerve-damage side, 25.8% of the TB-labeled cells were SP-positive. The value for the intact side was 12.0% (p less than 0.000001). This result demonstrated that the lesion-induced change in the percentage of SP-positive ION cells was not the result of either late-growing axons from SP-positive ganglion cells that may have been missed by our nerve cuts or collateral sprouting into the regenerate ION by undamaged SP-positive ganglion cells.     

Neonatal Transection Alters the Percentage of Substance-P-Positive Trigeminal Ganglion Cells That Contribute Axons to the Regenerate Infraorbital Nerve

Neonatal transection results in a marked reduction of the number of trigeminal (V) ganglion cells that contribute axons to the regenerate infraorbital nerve (ION; Jacquin and Rhoades, 1985; Chiaia et al., 1987). Such lesions also produce a profound deafferentation of the V brain stem complex that appears to spare the innervation of layers I and II of subnucleus caudalis (SpC) by subtance-P-positive (SP-positive) primary afferents (Jacquin and Rhoades, 1985; Rhoades et al., 1988). In the present study, we combined retrograde tracing with immunocytochemistry to determine whether neonatal transection of the ION alters the percentage of SP-positive V ganglion cells that contribute axons to this V branch upon regeneration. In V ganglia ipsilateral to the intact ION (n = 8), 11.6% ± 3.2% of the cells labeled after application of true blue (TB) to the ION were also SP-positive. In ganglia ipsilateral to the neonatally damaged nerve (n = 8), 18.6% ± 4.7% of the cells labeled after application of TB to the regenerate ION were also SP-positive (p < 0.001). We also compared the SP content of intact ganglia (n = 10) with that of ganglia ipsilateral to the damaged nerve (n = 10) by means of radioimmunoassay. The normal V ganglia contained (mean ± SD) 3496 ± 774 pg SP/mg protein. The value for the ganglia ipsilateral to the damaged nerve was 5533 ± 1746 pg SP/mg protein (p < 0.01). There was no significant difference between SP levels on the control and partially deafferented sides of the brain stem in neonatally nerve-damaged adult rats.

In one additional experiment, we injected TB into both vibrissa pads of seven rats on the day of birth prior to transection of the ION. After an 8-hr delay, the nerve on one side was then cut and allowed to regenerate, and both V ganglia were then processed for immunocytochemistry. On the nerve-damaged side, 25.8% of the TB-labeled cells were SP-positive. The value for the intact side was 12.0% (p < 0.00001). This result demonstrated that the lesion-induced change in the percentage of SP-positive ION cells was not1. the result of either late-growing axons from SP-positive ganglion cells that may have been missed by our nerve cuts or collateral sprouting into the regenerate ION by undamaged SP-positive ganglion cells.     

Chronic Restraint Stress Inhibits Hair Growth via Substance P Mediated by Reactive Oxygen Species in Mice

Backgrounds

Solid evidence has demonstrated that psychoemotional stress induced alteration of hair cycle through neuropeptide substance P (SP) mediated immune response, the role of reactive oxygen species (ROS) in brain-skin-axis regulation system remains unknown.

Objectives

The present study aims to investigate possible mechanisms of ROS in regulation of SP-mast cell signal pathway in chronic restraint stress (CRS, a model of chronic psychoemotional stress) which induced abnormal of hair cycle.

Methods and Results

Our results have demonstrated that CRS actually altered hair cycle by inhibiting hair follicle growth in vivo, prolonging the telogen stage and delaying subsequent anagen and catagen stage. Up-regulation of SP protein expression in cutaneous peripheral nerve fibers and activation of mast cell were observed accompanied with increase of lipid peroxidation levels and reduction of the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in CRS mice skin. In addition, SP receptor antagonist (RP67580) reduced mast cell activations and lipid peroxidation levels as well as increased GSH-Px activity and normalized hair cycle. Furthermore, antioxidant Tempol (a free radical scavenger) also restored hair cycle, reduced SP protein expression and mast cell activation.

Conclusions

Our study provides the first solid evidence for how ROS play a role in regulation of psychoemotional stress induced SP-Mast cell pathway which may provide a convincing rationale for antioxidant application in clinical treatment with psychological stress induced hair loss.     

Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation

Substance P (SP) was reported to be associated with eczema and acts as a potent skin mast cell secretagogue. However, little is known of its expression in inflammatory cells in eczema and its ability in induction of mast cell accumulation. In the present study, we investigated expression of SP and neurokinin-1 receptor (NK1R) on peripheral blood leukocytes and mast cells from patients with eczema and influence of SP on mast cell accumulation by using flow cytometry analysis, trans-epithelial cell migration assay and mouse peritoneal model. The results showed that plasma SP and IL-17A levels in eczema patients were higher than that in healthy control subject. The percentages of SP+ and NK1R+ expression populations of monocytes, helper T cells, natural killer T cells and basophils in peripheral blood of eczema patients were markedly elevated. It was observed that not only absolute number of mast cells but also SP+ and NK1R+ mast cells are enhanced in the lesion skin of eczema. SP showed a potent chemoattractant action on mast cells as assessed by a mouse peritoneal model and a trans-endothelium cell migration assay. SP-induced mast cell accumulation appears a CD18/CD11a complex, l-selectin and ICAM-1-dependent event which can be blocked by a NK-1R antagonist RP67580. In conclusion, elevated expression of SP in patients with eczema and the ability of SP in induction of mast cell accumulation indicate strongly that SP is a potent proinflammatory mediator, which contributes to the pathogenesis of eczema. Inhibitors of SP and blockers of NK1R are likely useful agents for treatment of eczema.     

Tachykinin receptor subtype that mediates the increase in vascular permeability in guinea pig skin

To determine the tachykinin receptor subtype that mediates the increase in vascular permeability, we examined the rank order of potency of tachykinins for inducing plasma extravasation in guinea pig skin and the specificity of tachykinin-induced tachyphylaxis of the responses. Plasma extravasation of the skin induced by tachykinins was NK-1 (SP-P)-type response from the rank order of potency of mammalian and nonmammalian tachykinins. Tachyphylaxis of the vascular response was induced by intradermal preinjection of mammalian tachykinins and was tachykinin-specific. In substance P (SP) tachyphylaxis (where SP was preinjected), the response to SP, not to neurokinin A (NKA) or neurokinin B (NKB), was decreased. In NKA tachyphylaxis and NKB tachyphylaxis, the response to NKA, not to SP or NKB, and the response to NKB, not to SP or NKA, were decreased, respectively. Thus, we conclude that the apparent NK-1-type response is mediated through three mammalian tachykinin receptors, NK-1, NK-2, and NK-3, which are specifically stimulated by their preferred agonist, SP, NKA, and NKB, respectively.     

5-HT(3) receptors mediate inflammation-induced unmasking of functional tachykinin responses in vitro.

Exogenously applied tachykinins produce no measurable electrophysiological responses in the somata of vagal afferent neurons [nodose ganglion neurons (NGNs)] isolated from naive guinea pigs. By contrast, after in vitro antigen challenge of nodose ganglia from guinea pigs immunized with chick ovalbumin, approximately 60% (53 of 89) of NGNs were depolarized an average of 13 +/- 1.2 mV by substance P (SP; 100 nM; n = 53). Receptor antagonists and enzyme inhibitors were utilized to screen a number of mast cell-derived mediators for their role in the uncovering or "unmasking" of functional tachykinin receptors after antigen challenge. Two chemically distinct 5-hydroxytryptamine-3-receptor antagonists significantly reduced the percentage of NGNs displaying depolarizing SP responses. Treatment with Y-25130 (1 or 10 microM) or tropisetron (1 microM) 15 min before and during antigen challenge reduced the percentage of SP-responsive neurons to approximately 20 and approximately 15% respectively. These results suggest that activation of 5-hydroxytryptamine-3 receptors plays an integral role in the unmasking of functional tachykinin receptors after specific antigen challenge of nodose ganglia. The mediator(s) underlying tachykinin-receptor unmasking in the remainder of the NGNs has yet to be characterized. However, it does not appear to be histamine, prostanoids, or peptidoleukotrienes.     

Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans

Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and TNF. Contact dermatitis and photosensitivity are skin conditions that involve non-immune triggers such as substance P (SP), and do not respond to conventional treatment. Inhibition of mast cell cytokine release could be effective therapy for such diseases. Unfortunately, disodium cromoglycate (cromolyn), the only compound marketed as a mast cell "stabilizer", is not particularly effective in blocking human mast cells. Instead, flavonoids are potent anti-oxidant and anti-inflammatory compounds with mast cell inhibitory actions. Here, we first compared the flavonoid quercetin (Que) and cromolyn on cultured human mast cells. Que and cromolyn (100 μM) can effectively inhibit secretion of histamine and PGD(2). Que and cromolyn also inhibit histamine, leukotrienes and PGD(2) from primary human cord blood-derived cultured mast cells (hCBMCs) stimulated by IgE/Anti-IgE. However, Que is more effective than cromolyn in inhibiting IL-8 and TNF release from LAD2 mast cells stimulated by SP. Moreover, Que reduces IL-6 release from hCBMCs in a dose-dependent manner. Que inhibits cytosolic calcium level increase and NF-kappa B activation. Interestingly, Que is effective prophylactically, while cromolyn must be added together with the trigger or it rapidly loses its effect. In two pilot, open-label, clinical trials, Que significantly decreased contact dermatitis and photosensitivity, skin conditions that do not respond to conventional treatment. In summary, Que is a promising candidate as an effective mast cell inhibitor for allergic and inflammatory diseases, especially in formulations that permit more sufficient oral absorption.